表观遗传学与CAR-T细胞疗法相遇,以对抗癌症
Simeon Santourlidis1, Marcos J Araúzo-Bravo2,3,4, Lars Erichsen1,5
1Institute of Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.
Cancers
|May 25, 2024
概括
化学抗原受体T细胞 (Car-T) 疗法通过DNA低甲基化查识别新的标,对固体瘤显示出前景. 这种方法可能会导致针对前列腺癌等癌症的新治疗方法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 化学抗原受体T细胞 (Car-T) 疗法在治疗血液癌症方面取得了显著的成功.
- 将Car-T疗法扩展到固体瘤面临挑战,特别是在识别特定的癌细胞点方面.
研究的目的:
- 探索DNA低甲基化作为一种发现新型细胞表面向抗原的方法,用于固体瘤的Car-T疗法.
- 为了研究这种方法在前列腺癌治疗中的潜在应用.
主要方法:
- 利用全基因组查来识别瘤中一致的DNA低甲基化.
- 分析低甲基化区域以找到异常上调的转录,可能编码细胞表面蛋白质.
主要成果:
- 低甲基化查提供了一种新的策略,用于在各种瘤类型中识别潜在的Car-T细胞标.
- 这种方法为发现固体瘤免疫疗法的抗原提供了新的视角.
结论:
- DNA低甲基化查是一种有前途的方法,用于在固体瘤中识别新的Car-T治疗点.
- 这一策略有可能开发新的免疫疗法,从前列腺癌开始.
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


